163 related articles for article (PubMed ID: 31054116)
1. The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis.
Mihai G; Gasparik AI; Pascanu IM; Cevei M; Hutanu A; Pop RM
Aging Clin Exp Res; 2019 Jun; 31(6):889-895. PubMed ID: 31054116
[TBL] [Abstract][Full Text] [Related]
2. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver.
Shaker O; El-Shehaby A; Zakaria A; Mostafa N; Talaat S; Katsiki N; Mikhailidis DP
Clin Biochem; 2011 Dec; 44(17-18):1457-63. PubMed ID: 21939650
[TBL] [Abstract][Full Text] [Related]
3. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
[TBL] [Abstract][Full Text] [Related]
4. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women.
Tohidi M; Akbarzadeh S; Larijani B; Kalantarhormozi M; Ostovar A; Assadi M; Vahdat K; Farrokhnia M; Sanjdideh Z; Amirinejad R; Nabipour I
Bone; 2012 Nov; 51(5):876-81. PubMed ID: 22971441
[TBL] [Abstract][Full Text] [Related]
5. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
6. Retinol, retinol-binding protein 4, abdominal fat mass, peak bone mineral density, and markers of bone metabolism in men: the Northern Osteoporosis and Obesity (NO2) Study.
Högström M; Nordström A; Nordström P
Eur J Endocrinol; 2008 May; 158(5):765-70. PubMed ID: 18426837
[TBL] [Abstract][Full Text] [Related]
7. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
8. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
9. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
10. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.
Iacobellis G; Iorio M; Napoli N; Cotesta D; Zinnamosca L; Marinelli C; Petramala L; Minisola S; D'Erasmo E; Letizia C
J Endocrinol Invest; 2011 Jan; 34(1):e12-5. PubMed ID: 20634640
[TBL] [Abstract][Full Text] [Related]
11. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
[TBL] [Abstract][Full Text] [Related]
12. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Terzoudis S; Malliaraki N; Damilakis J; Dimitriadou DA; Zavos C; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):814-9. PubMed ID: 26934527
[TBL] [Abstract][Full Text] [Related]
13. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects.
Goktas Z; Owens S; Boylan M; Syn D; Shen CL; Reed DB; San Francisco S; Wang S
Mediators Inflamm; 2013; 2013():861496. PubMed ID: 24367155
[TBL] [Abstract][Full Text] [Related]
14. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
[TBL] [Abstract][Full Text] [Related]
15. Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females.
Tariq S; Tariq S; Khaliq S; Abualhamael SA; Baig M
Front Endocrinol (Lausanne); 2022; 13():1024860. PubMed ID: 36531488
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients.
Haider DG; Schindler K; Mittermayer F; Müller M; Nowotny P; Rieger A; Luger A; Ludvik B; Wolzt M
Clin Pharmacol Ther; 2007 Apr; 81(4):580-5. PubMed ID: 17235334
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
18. Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.
Schindler K; Haider D; Wolzt M; Rieger A; Gmeinhart B; Luger A; Nowotny P; Ludvik B
Eur J Clin Invest; 2006 Sep; 36(9):640-6. PubMed ID: 16919047
[TBL] [Abstract][Full Text] [Related]
19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
20. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women.
Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH
J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
